SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
HUMA

Humacyte, Inc. (NASDAQ:HUMA)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.40-0.03 (-7.99%)
 
Market cap
$111M
Insider Score
Analyst consensus
Listed since
Dec 1, 2020
Insider Score
/ 100
HUMA Insider Score

Humacyte, Inc. has a live Insider Score.

Scored on 3 qualifying trades from 1 insider in the last 90 days.

Unlock the score

Congress Trading

Recent trades of HUMA by members of U.S. Congress

PoliticianTypeTraded
Tommy TubervilleSenate / RPurchase$1.00K – $15.00KMar 21, 2024
Tommy TubervilleSenate / RPurchase$15.00K – $50.00KMar 21, 2024

Corporate Lobbying

Government lobbying spending instances

Loading filings…

Source: U.S. Senate LDA

Corporate Lobbying

HUMA Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New HUMA patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to HUMA from public contracts

Source: USAspending.gov

Recently reported changes in HUMA holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Congressional Trades

U.S. House and Senate disclosures referencing HUMA, reported under the STOCK Act.

PoliticianChamberActionAmountDate
SenateBuy$1.00K – $15.00KMar 21, 2024
SenateBuy$15.00K – $50.00KMar 21, 2024
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.